Recombinant single domain antibody specifically binds to human SOD1. It could block fibril formation by SODl and reduce SODl aggregation in HeLa cells. The single domain antibody is particularly envisaged for treatment of ALS.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.